Clinical trial

Hypofractionated Stereotactic Boost in Prostate Cancer

NCT01596816

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-08-31

PhasePHASE2

Study timeline

Study start (actual)2010-08-31Date precision: day

Registry last updated2026-03-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cancerunresolved

Interventions

First part of treatment : Conformal irradiationRADIATION

Fiducials placementPROCEDURE

Second part : hypofractionated stereotactic boostRADIATION

Sponsors & collaborators

Centre Oscar Lambretlead sponsor

National Cancer Institute, Francecollaborator

Mapped research locations

MontpellierFrance1 LyonFrance1 LilleFrance1 DijonFrance1 AngersFrance1 Vandœuvre-lès-NancyFrance1 Pierre-BéniteFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01596816 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.